700. Safety and Efficacy of Omadacycline in Patients with Diabetes in Phase 3 Clinical Studies

BACKGROUND: The risk of serious infections and poor treatment outcomes is reported to be higher in patients with diabetes compared with the general population. Omadacycline (OMC) is an intravenous (IV) and oral aminomethylcycline antibiotic approved in the US to treat acute bacterial skin and skin s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pai, Manjunath P, Wilcox, Mark H, Curran, Marla, Chitra, Surya, Garrity-Ryan, Lynne, McGovern, Paul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811084/
http://dx.doi.org/10.1093/ofid/ofz360.768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811084/
http://dx.doi.org/10.1093/ofid/ofz360.768

Ejemplares similares